XC-12 is an orally active, potent small-molecule inhibitor of CD73 (an immune checkpoint), with IC50 values of 12.36 nM for the soluble form and 1.29 nM for the membrane-bound form. XC-12 holds promise for cancer research.
Target:
CD73
* VAT and and shipping costs not included. Errors and price changes excepted
